The Examination of the Escape Phenomenon of the Disease Modifying Antirheumatic Drugs
Yoichi Kawasaki+3 more
openalex +2 more sources
Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis. [PDF]
Fazel SD+5 more
europepmc +1 more source
Real-World Treatment Effectiveness of Disease-Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis. [PDF]
Jin Y, Liu J, Desai RJ, Kim SC.
europepmc +1 more source
Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort [PDF]
Ruben Tavares+23 more
openalex +1 more source
Comparison of the Efficacy and Safety of Disease-Modifying Antirheumatic Drugs Combination Therapies: A Systematic Review and Network Meta-Analysis. [PDF]
Liu L+5 more
europepmc +1 more source
Initiation of Disease-Modifying Antirheumatic Drugs in Older Medicare Beneficiaries With New Diagnosis of Late-Onset Rheumatoid Arthritis. [PDF]
Lee J+5 more
europepmc +1 more source
Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment [PDF]
Annelieke Pasma+5 more
openalex +1 more source
Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis [PDF]
Baeten, Dominique+9 more
core
Pregnancy Outcomes of Targeted Synthetic Disease-Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review. [PDF]
Cheng V+7 more
europepmc +1 more source
Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs [PDF]
Tsutomu Takeuchi+8 more
openalex +1 more source